5 results
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
pharmacotherapy trials in BPD ... following outcomes: BPD ... placebo-controlled Managing BPD ... the UK national BPD ... #BPD #Borderline
Benzodiazepine (BZD) withdrawal: clinical findings and complications

 • Activation of ACC and OFC -> Feelings of
Benzodiazepine (BZD ... Activity -> Incr BP ... Benzodiazepine #BZD ... #withdrawal #pharmacology ... #symptoms
Therapy for Benign Prostatic Hyperplasia (BPH) 
5 Alpha-Reductase inhibitors
 • Flnasterlde and dutasterlde act by reducing
(BPH) 5 Alpha-Reductase ... of BPH, such as ... acute urinary retention ... #BPH #Prostate ... #Medications #Pharmacology
Benign Prostatic Hyperplasia: Pathogenesis and Clinical Findings

Hormonal alterations (result of aging process)
    ->
Benign Prostatic Hyperplasia ... Hydronephrosis, Acute ... bladder stones #BPH ... Benign #Prostatic #Hyperplasia ... Pathophysiology #Urology #Signs
Lithium Therapy for Bipolar Disorder 
Toxicity Levels: 
 - Mild (1-1.5 mEq/L) 
 - Moderate (1.6-2.5
gain Toxicity Symptoms ... Lithium is a medication ... experience a variety of symptoms ... Bipolar #Disorder #BPD ... #Toxicity #Pharmacology